Cui Y, Chen H, Xi R, Cui H, Zhao Y, Xu E, Yan T, Lu X, Huang F, Kong P, et al. Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma. Cell Res. 2020;30(10):902–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao R, Tang W, Chen S. Association between BTLA polymorphisms and susceptibility to esophageal squamous cell carcinoma in the Chinese population. J Clin Lab Anal. 2020;34(6):e23221.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Waters JK, Reznik SI. Update on management of squamous cell esophageal Cancer. Curr Oncol Rep. 2022;24(3):375–85.

Article  CAS  PubMed  Google Scholar 

Hu Y, Liu F, Jia X, Wang P, Gu T, Liu H, Liu T, Wei H, Chen H, Zhao J, et al. Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3. Oncogene. 2021;40(23):3942–58.

Article  CAS  PubMed  Google Scholar 

Wang ZX, Cui C, Yao J, Zhang Y, Li M, Feng J, Yang S, Fan Y, Shi J, Zhang X, et al. Toripalimab plus chemotherapy in treatment-naive, advanced esophageal squamous cell carcinoma (JUPITER-06): a multi-center phase 3 trial. Cancer Cell. 2022;40(3):277–e288273.

Article  CAS  PubMed  Google Scholar 

Thuss-Patience P, Stein A. Immunotherapy in squamous cell Cancer of the Esophagus. Curr Oncol. 2022;29(4):2461–71.

Article  PubMed  PubMed Central  Google Scholar 

Yang YM, Hong P, Xu WW, He QY, Li B. Advances in targeted therapy for esophageal cancer. Signal Transduct Target Ther. 2020;5(1):229.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Imazeki H, Kato K. Development of chemotherapeutics for unresectable advanced esophageal cancer. Expert Rev Anticancer Ther. 2020;20(12):1083–92.

Article  CAS  PubMed  Google Scholar 

Shah MA, Kojima T, Hochhauser D, Enzinger P, Raimbourg J, Hollebecque A, Lordick F, Kim SB, Tajika M, Kim HT, et al. Efficacy and safety of Pembrolizumab for heavily pretreated patients with Advanced, metastatic adenocarcinoma or squamous cell carcinoma of the Esophagus: the phase 2 KEYNOTE-180 study. JAMA Oncol. 2019;5(4):546–50.

Article  PubMed  Google Scholar 

Fatehi Hassanabad A, Chehade R, Breadner D, Raphael J. Esophageal carcinoma: towards targeted therapies. Cell Oncol (Dordr). 2020;43(2):195–209.

Article  PubMed  Google Scholar 

Hua Y, Zheng Y, Yao Y, Jia R, Ge S, Zhuang A. Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing. J Transl Med. 2023;21(1):403.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Menter DG, Bresalier RS. An aspirin a day: New Pharmacological developments and Cancer Chemoprevention. Annu Rev Pharmacol Toxicol. 2023;63:165–86.

Article  CAS  PubMed  Google Scholar 

Champion MC, Hartnett M, Yen M. Domperidone, a new dopamine antagonist. CMAJ. 1986;135(5):457–61.

CAS  PubMed  PubMed Central  Google Scholar 

Reddymasu SC, Soykan I, McCallum RW. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol. 2007;102(9):2036–45.

Article  CAS  PubMed  Google Scholar 

Mehrabadi A, Reynier P, Platt RW, Filion KB. Domperidone for insufficient lactation in England 2002–2015: a drug utilization study with interrupted time series analysis. Pharmacoepidemiol Drug Saf. 2018;27(12):1316–24.

Article  CAS  PubMed  Google Scholar 

Puoti MG, Assa A, Benninga MP, Broekaert IJ, Carpi FJM, Saccomani MD, Dolinsek JP, Homan M, Mas EP, Miele EP et al. Drugs in focus: Domperidone. J Pediatr Gastroenterol Nutr 2023.

Suain Bon R, Mahmud AA. Domperidone Use as a Galactagogue and Infanticide ideation: a Case Report. Breastfeed Med. 2022;17(8):698–701.

Article  PubMed  Google Scholar 

Thistle JE, Petrick JL, Yang B, Bradley MC, Graubard BI, McGlynn KA. Domperidone use and risk of primary liver cancer in the clinical Practice Research Datalink. Cancer Epidemiol. 2018;55:170–5.

Article  PubMed  PubMed Central  Google Scholar 

Ullah R, Yin Q, Snell AH, Wan L. RAF-MEK-ERK pathway in cancer evolution and treatment. Semin Cancer Biol. 2022;85:123–54.

Article  CAS  PubMed  Google Scholar 

Samatar AA, Poulikakos PI. Targeting RAS-ERK signalling in cancer: promises and challenges. Nat Rev Drug Discov. 2014;13(12):928–42.

Article  CAS  PubMed  Google Scholar 

Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26(22):3291–310.

Article  CAS  PubMed  Google Scholar 

Sebolt-Leopold JS. MEK inhibitors: a therapeutic approach to targeting the Ras-MAP kinase pathway in tumors. Curr Pharm Des. 2004;10(16):1907–14.

Article  CAS  PubMed  Google Scholar 

Long GV, Hauschild A, Santinami M, Atkinson V, Mandala M, Chiarion-Sileni V, Larkin J, Nyakas M, Dutriaux C, Haydon A, et al. Adjuvant dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma. N Engl J Med. 2017;377(19):1813–23.

Article  CAS  PubMed  Google Scholar 

Liu F. Smad3 phosphorylation by cyclin-dependent kinases. Cytokine Growth Factor Rev. 2006;17(1–2):9–17.

Article  PubMed  Google Scholar 

Liu F. Inhibition of Smad3 activity by cyclin D-CDK4 and cyclin E-CDK2 in breast cancer cells. Cell Cycle. 2011;10(2):186.

Article  CAS  PubMed  Google Scholar 

Liu F, Matsuura I. Inhibition of smad antiproliferative function by CDK phosphorylation. Cell Cycle. 2005;4(1):63–6.

Article  CAS  PubMed  Google Scholar 

Wei Y, Wu W, Jiang Y, Zhou H, Yu Y, Zhao L, Wu X, Lu X, Yuan Q, Wang Z, et al. Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4. Br J Cancer. 2022;126(7):1037–46.

Article  CAS  PubMed  Google Scholar 

Bao Z, Li A, Lu X, Wang Z, Yu Y, Wu W, Zhao L, Li B, Wu X, Laster KV, et al. Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A. Cell Death Dis. 2022;13(2):189.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang P, Jia X, Lu B, Huang H, Liu J, Liu X, Wu Q, Hu Y, Li P, Wei H, et al. Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2. Signal Transduct Target Ther. 2023;8(1):96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang L, Bockorny B, Paul I, Akshinthala D, Frappart PO, Gandarilla O, Bose A, Sanchez-Gonzalez V, Rouse EE, Lehoux SD et al. PDX-derived organoids model in vivo drug response and secrete biomarkers. JCI Insight 2020, 5(21).

Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol. 2021;18(6):432–43.

Article  PubMed  Google Scholar 

Moody S, Senkin S, Islam SMA, Wang J, Nasrollahzadeh D, Cortez Cardoso Penha R, Fitzgerald S, Bergstrom EN, Atkins J, He Y, et al. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat Genet. 2021;53(11):1553–63.

Article  CAS  PubMed  Google Scholar 

Liu L, Lin C, Liang W, Wu S, Liu A, Wu J, Zhang X, Ren P, Li M, Song L. TBL1XR1 promotes lymphangiogenesis and lymphatic metastasis in esophageal squamous cell carcinoma. Gut. 2015;64(1):26–36.

Article  CAS  PubMed  Google Scholar 

Wu Q, Liu F, Ge M, Laster KV, Wei L, Du R, Jiang M, Zhang J, Zhi Y, Jin G, et al. BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression. Oncogene. 2022;41(3):347–60.

Article  CAS  PubMed  Google Scholar 

He X, Zhou Y, Chen W, Zhao X, Duan L, Zhou H, Li M, Yu Y, Zhao J, Guo Y, et al. Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma. Oncogene. 2023;42(15):1209–23.

Article  CAS  PubMed  Google Scholar 

Zelivianski S, Cooley A, Kall R, Jeruss JS. Cyclin-dependent kinase 4-mediated phosphorylation inhibits Smad3 activity in cyclin D-overexpressing breast cancer cells. Mol Cancer Res. 2010;8(10):1375–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lim H, He D, Qiu Y, Krawczuk P, Sun X, Xie L. Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology. PLoS Comput Biol. 2019;15(6):e1006619.

Article  CAS  PubMed  PubMed Central